Ultra-efficient chip design enables extremely strong cryptography algorithms to run on energy-constrained edge devices.

Mitali Chowdhury ’24 and Christina Kim ’24 will pursue graduate studies at Cambridge University in the UK.

A new study suggests that the chemical NDMA is much more likely to cause cancerous mutations after exposure early in life.

Long thought to be mainly a structural support, the cell membrane also influences how cells respond to signals and may contribute to the growth of cancer cells.

Startup accelerator program grows to over 30 companies, almost half of them with MIT pedigrees.

Study finds a common bacterium can suppress the body’s early warning system in wounds, causing infections to persist and create an environment that allows other bacteria to take hold.

A new biohybrid system developed at MIT is the first living implant that uses rewired nerves to revive paralyzed organs.

An AI model generates novel proteins based on how they vibrate and move, opening new possibilities for dynamic biomaterials and adaptive therapeutics.

A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.

The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.

A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.

As an aspiring physician-scientist and editor-in-chief of The Tech, MIT senior Alex Tang has found inspiration in the lives of patients and others in his community.

As an aspiring physician-scientist and editor-in-chief of The Tech, MIT senior Alex Tang has found inspiration in the lives of patients and others in his community.

An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.

Anthropologist Amy Moran-Thomas studies overlooked insights from people health care is meant to reach.

Tsai, who has grown the MIT neuroscience institute, will increase focus on research including Alzheimer’s disease and Down syndrome.

SMART breakthrough offers a promising pathway toward improved manufacturing of high‑quality cells for regenerative therapies to treat joint diseases.

MIT senior Srihitha Dasari reflects on the power of experiential learning through the PKG Center for Social Impact.

The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.

By showing the problem derives from genetic mutations that lead to overexpression of a microRNA, MIT researchers’ study points to potential treatment.

Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.

Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.

Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.

From early motion-sensing platforms to environmental monitoring, the professor and head of the Program in Media Arts and Sciences has turned decades of cross-disciplinary research into real-world impact.

In Compton Lecture at MIT, social psychologist Jonathan Haidt warns of dramatic global decay in cognition, attention spans, and civic life, and urges curbs to tech use.

The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.

Assistant Professor Alison Ringel will investigate the intersection of immunology and aging biology, aiming to define mechanisms that underlie aging-related decline, thanks to a grant from the foundation.

By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.

Researchers find mice modeling the autism spectrum disorder fragile X syndrome exhibit the same pattern of differences in low-frequency waves as humans — a new marker for treatment studies.

Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.

Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.

WITEC is working to develop the first wearable ultrasound imaging system to monitor chronic conditions in real-time, with the goal of enabling earlier detection and timely intervention.

The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.

The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.

Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.

Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.

Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.

Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.

New research suggests liver cells exposed to too much fat revert to an immature state that is more susceptible to cancer-causing mutations.

Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.

A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.

Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.

Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.

Preliminary studies find derivatives of the compound, known as verticillin A, can kill some types of glioma cells.

The approach could transform large-scale biomanufacturing by enabling automated and contamination-conscious workflows for cell therapies, tissue engineering, and regenerative medicine.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.

An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.

A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.

The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.